4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-056681
Chief Business Officer sold 6,944 shares at $31.27 ($217,153)
- Chief Business Officer acquired 6,944 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parrish Jay · Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 1 in the form | +4,629 | $1.49 | $6,874 | 226,851 | D |
| 2020-11-02 | Exercise or conversion : show line 2 in the form | +2,315 | $1.58 | $3,646 | 229,166 | D |
| 2020-11-02 | Sale : show line 3 in the form | −6,944 | $31.27 | $217,153 | 222,222 | D |
| Open-market sales · 6,944 sh · avg $31.27 · $217,153 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −4,629 | 27,778 | D |
| 2020-11-02 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −2,315 | 48,611 | D |
Loading xslF345X03/doc4.xml…